Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Published in Oncology

Journal Scan / Consensus and Guidelines · June 25, 2022

ASCO Guideline Update for Systemic Therapy for HER2+ Advanced Breast Cancer

Journal of Clinical Oncology

 

 Save  Recommend
 Share

Additional Info

Journal of Clinical Oncology
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update
J. Clin. Oncol 2022 May 31;[EPub Ahead of Print], SH Giordano, MAB Franzoi, S Temin, CK Anders, S Chandarlapaty, JR Crews, JJ Kirshner, IE Krop, NU Lin, A Morikawa, DA Patt, J Perlmutter, N Ramakrishna, NE Davidson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated